Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 14/20 | 0.56 |
| ▸ | RARA | P10276 | 1/20 | 0.45 |
| ▸ | RARB | P10826 | 1/20 | 0.45 |
| ▸ | HCAR3 | P49019 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9070871 | 0.90 | GCK (0.66) | GCKRARARARBHCAR3 | |
| SCHEMBL9070873 | 0.85 | GCK (0.64) | GCKRARARARB | |
| SCHEMBL2667714 | 0.82 | GCK (0.76) | GCKRARARARB | |
| SCHEMBL2667604 | 0.81 | GCK (0.57) | GCKRARARARBHCAR3 | |
| SCHEMBL2667932 | 0.80 | GCK (0.51) | GCKRARARARBHCAR3 | |
| SCHEMBL9070821 | 0.77 | GCK (0.55) | GCKRARARARBHCAR3 | |
| SCHEMBL9070823 | 0.77 | GCK (0.54) | GCKRARARARBHCAR3 | |
| SCHEMBL2667954 | 0.77 | GCK (0.76) | GCKRARARARB | |
| SCHEMBL9070896 | 0.76 | HCAR3 (0.52) | GCKRARARARBHCAR3 | |
| SCHEMBL9070824 | 0.76 | SMN1; SMN2 (0.44) | NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009083553-A1 | AZINE COMPOUNDS AS GLUCOKINASE ACTIVATORS | RHEOSCIENCE A/S (DK) | 2009-07-09 | — | — | WO | disclosed |